Results
|
1561.
|
Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber. [electronic resource] by
- Bousquet, Jean
- Meltzer, Eli O
- Couroux, Peter
- Koltun, Arkady
- Kopietz, Ferdinand
- Munzel, Ullrich
- Kuhl, Hans Christian
- Nguyen, Duc Tung
- Salapatek, Anne Marie
- Price, David
Producer: 20191114
In:
The journal of allergy and clinical immunology. In practice vol. 6
Availability: No items available.
|
|
1562.
|
|
|
1563.
|
BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors. [electronic resource] by
- Reisländer, Timo
- Lombardi, Emilia Puig
- Groelly, Florian J
- Miar, Ana
- Porru, Manuela
- Di Vito, Serena
- Wright, Benjamin
- Lockstone, Helen
- Biroccio, Annamaria
- Harris, Adrian
- Londoño-Vallejo, Arturo
- Tarsounas, Madalena
Producer: 20191223
In:
Nature communications vol. 10
Availability: No items available.
|
|
1564.
|
|
|
1565.
|
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline [electronic resource] by
- Litton, Jennifer K
- Scoggins, Marion E
- Hess, Kenneth R
- Adrada, Beatriz E
- Murthy, Rashmi K
- Damodaran, Senthil
- DeSnyder, Sarah M
- Brewster, Abenaa M
- Barcenas, Carlos H
- Valero, Vicente
- Whitman, Gary J
- Schwartz-Gomez, Jill
- Mittendorf, Elizabeth A
- Thompson, Alastair M
- Helgason, Thorunn
- Ibrahim, Nuhad
- Piwnica-Worms, Helen
- Moulder, Stacy L
- Arun, Banu K
Producer: 20200908
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 38
Availability: No items available.
|
|
1566.
|
Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib. [electronic resource] by
- de Haan, R
- van Werkhoven, E
- van den Heuvel, M M
- Peulen, H M U
- Sonke, G S
- Elkhuizen, P
- van den Brekel, M W M
- Tesselaar, M E T
- Vens, C
- Schellens, J H M
- van Triest, B
- Verheij, M
Producer: 20200228
In:
BMC cancer vol. 19
Availability: No items available.
|
|
1567.
|
|
|
1568.
|
|
|
1569.
|
|
|
1570.
|
|
|
1571.
|
Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition. [electronic resource] by
- Yang, Lu
- Zhang, Youyou
- Shan, Weiwei
- Hu, Zhongyi
- Yuan, Jiao
- Pi, Jingjiang
- Wang, Yueying
- Fan, Lingling
- Tang, Zhaoqing
- Li, Chunsheng
- Hu, Xiaowen
- Tanyi, Janos L
- Fan, Yi
- Huang, Qihong
- Montone, Kathleen
- Dang, Chi V
- Zhang, Lin
Producer: 20180417
In:
Science translational medicine vol. 9
Availability: No items available.
|
|
1572.
|
|
|
1573.
|
Epidermal Growth Factor Receptor-Targeting Peptide Nanoparticles Simultaneously Deliver Gemcitabine and Olaparib To Treat Pancreatic Cancer with Breast Cancer 2 ( BRCA2) Mutation. [electronic resource] by
- Du, Chong
- Qi, Yingqiu
- Zhang, Yinlong
- Wang, Yazhou
- Zhao, Xiao
- Min, Huan
- Han, Xuexiang
- Lang, Jiayan
- Qin, Hao
- Shi, Quanwei
- Zhang, Zhengkui
- Tian, Xiaodong
- Anderson, Greg J
- Zhao, Ying
- Nie, Guangjun
- Yang, Yinmo
Producer: 20191014
In:
ACS nano vol. 12
Availability: No items available.
|
|
1574.
|
|
|
1575.
|
|
|
1576.
|
|
|
1577.
|
|
|
1578.
|
|
|
1579.
|
|
|
1580.
|
|